Skip to main content
. 2018 Jul 6;7(7):52. doi: 10.1038/s41389-018-0061-7

Fig. 6. Effect of FOXC1 on proliferation and EMT of xenograft tumors.

Fig. 6

a Western blot analysis of proliferation markers in FOXC1-silenced HPAC xenograft tumors and b FOXC1-overexpressing MIA PaCa-2 xenograft tumors. c Western blot analysis of EMT markers in FOXC1-silenced HPAC xenograft tumors and d FOXC1-overexpressing MIA PaCa-2 xenograft tumors. e Immunohistochemical analysis of Ki67, Gli1, and VEGFR2 in FOXC1-silenced HPAC xenograft tumors and f FOXC1-overexpressing MIA PaCa-2 xenograft tumors. Data shown as mean ± SEM. Experiments (n = 3) were repeated three times. *p < 0.05